The United Arab Emirates is a prime market for MedTech expansion, but entry is guarded by a critical gatekeeper: the Local Authorized Representative. This role is far more than a simple administrative requirement; it is a legal necessity that holds significant sway over a manufacturer's success and compliance. This episode of MedTech Global Insights explores the essential functions, legal responsibilities, and strategic importance of the UAE Authorized Representative. We uncover the day-to-day duties of a representative, from managing initial MOHAP registration to handling critical post-market surveillance and vigilance reporting. We also dissect the common but risky practice of appointing a distributor for this role and explain how this can jeopardize your market access and create long-term complications. Consider this scenario: A European MedTech company appoints its UAE distributor as its Authorized Representative to save on costs. A year later, they decide to switch to a new, more effective distributor. However, they discover the product registration is legally held by the original distributor, who is now unwilling to transfer it without a substantial fee. The company is now trapped: either pay the exorbitant fee or pull their product from the market and start the entire costly registration process over with a new representative, losing over a year of sales and market presence. Key Takeaways: - Is appointing your distributor as your legal representative a strategic shortcut or a long-term liability? - What are the specific legal responsibilities your company is delegating to your UAE representative? - How can the wrong representative choice lead to a complete loss of market access during a distributor change? - What are the key differences in post-market vigilance requirements between the EU and the UAE that your representative must know? - How do you verify if a potential representative has the expertise to handle complex interactions with MOHAP? - Why is an independent representative crucial for maintaining control over your product registration and intellectual property? - What happens if your representative fails to properly report an adverse event to the authorities? For more information, contact us at [email protected] or visit https://pureglobal.com/.
Fler avsnitt av MedTech Global Insights
Visa alla avsnitt av MedTech Global InsightsMedTech Global Insights med Ran Chen finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
